NEW ORLEANS SOCIETY FOR INFECTIOUS DISEASE AWARENE (EIN 272213596) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2010

Legal Domicile

Phone

7312342971

Tax Period

2024-07-01 to 2025-06-30

NEW ORLEANS SOCIETY FOR INFECTIOUS DISEASE AWARENE, founded in 2010, is a micro nonprofit in the Diseases & Disorders sector that reported $32K in total revenue in fiscal year 2024. Revenue surged 41% from the prior year, signaling strong growth momentum. Expenses of $35K exceeded revenue, resulting in a 10% operating deficit.

Mission

TO RAISE AWARENESS OF HIV/AIDS IN NEW ORLEANS THROUGH THE USE OF MUSIC

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $31,806

Program Service Revenue $0

Investment Income $0

Other Revenue $0

TOTAL REVENUE $31,806

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $4,872

Program Expenses $17,718

Other Expenses $34,663

TOTAL EXPENSES $35,104

Year-over-Year Comparison

	2024	2023	Change
Revenue	$31,806	$22,607	+0.4%
Expenses	$35,104	$57,154	-0.4%
Net Income	$-3,298	$-34,547	-0.9%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Role	Reportable Comp	Other Comp	Total
MARKALAIN DERY	PRESIDENT	Officer Director	$0	$0	$0
KELLY BURKE	TREASURER	Officer Director	$0	$0	$0
LIANA ELLIOTT	CHAIRWOMAN OF THE BOARD	Officer Director	$0	$0	$0
JIM PALACIOS	BOARD MEMBER	Director	$0	$0	$0
DAVID ABDULLAH	BOARD MEMBER	Director	$0	$0	$0
CHRISTOPHER ARD	BOARD MEMBER	Director	$0	$0	$0
AMY IRVIN	BOARD MEMBER	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$31,806	$35,104	$104,916	$-3,298
2024	$22,607	$57,154	$108,275	$-34,547
2023	$64,303	$81,937	$129,191	$-17,634

NEW ORLEANS SOCIETY FOR INFECTIOUS DISEASE AWARENE